Chronic News and Research

RSS

HDL to acquire Harris Scientific

Health Diagnostic Laboratory Inc., a CAP accredited leader in health management, announced today that it will expand its comprehensive test menu of risk factors and biomarkers for cardiovascular and related diseases through the acquisition of Harris Scientific, Inc., a company providing omega-3 fatty acid testing based on the research of Dr. William Harris.

25 May 2011

New cancer study finds benefit in old therapy

Cancer patients who used a 5,000-year-old combination of gentle exercise and meditation experienced significantly higher wellbeing levels, improved cognitive functioning and less inflammation compared to a control group, new University of Sydney research has found.

24 May 2011

Nerve stimulation device approved for pain

The Medtronic Inc. has won the CE Mark approval for a peripheral nerve stimulation device for treating chronic back pain. This medical device maker from Minneapolis, Minn. said the implantable device will fit into its neurostimulation business, which operates out of the company's restorative therapies division. That unit was responsible for about $5.42 billion in sales during the nine-month period ended Jan. 28.

From Medtronic 24 May 2011

Disaster-response planning raises challenges for mental health services, bioethicists say

Johns Hopkins University bioethicists say disaster-response planning has generally overlooked the special needs of people who suffer from pre-existing and serious mental conditions.

24 May 2011

Galectin-3 research uncovers new use for Modified Citrus Pectin in cardiovascular, heart disease

In a new important research study out of the UK, scientists found that the specific form of Modified Citrus Pectin developed by Isaac Eliaz, M.D. interrupts deadly kidney fibrosis by binding to galectin-3 molecules, decreasing the effects of inflammation and fibrosis in acute kidney injury.

24 May 2011

Analysis of Nubian-era mummies finds schistosomiasis spread from altering environment

Mummies from along the Nile are revealing how age-old irrigation techniques may have boosted the plague of schistosomiasis, a water-borne parasitic disease that infects an estimated 200 million people today.

24 May 2011

NIAID team completes analysis of most proteins produced by elephantiasis parasite worm

A team led by Thomas B. Nutman, M.D., of the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, has completed a large-scale analysis of most of the proteins produced by Brugia malayi, one kind of parasitic worm that causes lymphatic filariasis, or elephantiasis.

24 May 2011

Ford engineers develop car seat that can monitor driver's heartbeat

Ford engineers have developed a car seat that can monitor a driver's heartbeat, opening the door to a wealth of health, convenience and even life-saving potential.

24 May 2011

RACGP urges government to engage with profession regarding GP mental health funding cuts

The Royal Australian College of General Practitioners (RACGP) continues to receive feedback from amongst its over 20,000 members regarding the implications of the government’s budget cuts for critical mental health support delivered by GPs. The College urges the government to engage with the profession regarding the cuts to GP mental health assessments, planning and referrals.

24 May 2011

NIH awards $3.03 million grant to UTMB researcher to continue groundbreaking aging study

Rebeca Wong, one of the nation's foremost experts on aging, has been awarded $3.03 million by the National Institute on Aging of the National Institutes of Health to continue a groundbreaking study in Mexico. Wong will use the grant for a longitudinal aging study she and collaborators started in 2001.

24 May 2011

Vertex Incivek receives FDA approval for treatment of chronic hepatitis C

The U.S. Food and Drug Administration today approved Incivek treat certain adults with chronic hepatitis C infection. Incivek is used for patients who have either not received interferon-based drug therapy for their infection or who have not responded adequately to prior therapies. Incivek is approved for use with interferon therapy made up of peginterferon alfa and ribavirin.

24 May 2011

Terminally ill missing out on palliative care: Survey reports

According to two new surveys, increased hospital admissions in the last three months of life could be of little benefit to dying people and are in contrast to the wishes of many.

23 May 2011

Johns Hopkins bioethicists urge disaster preparedness for mentally impaired

Johns Hopkins bioethicists say disaster-response planning has generally overlooked the special needs of people who suffer from pre-existing and serious mental conditions. Survivors already diagnosed with schizophrenia, dementia, addictions and bipolar disorder are vulnerable long before a disaster strikes, they point out.

23 May 2011

HIV-infected donors present novel source of organs for HIV-infected transplant candidates

A new study published in the American Journal of Transplantation reveals that HIV-infected deceased donors represent a potentially novel source of organs for HIV-infected transplant candidates that could decrease waitlist deaths and even shorten the national waitlist.

23 May 2011

Positive results from Relypsa RLY5016 Phase 2 trial to be presented at American Society of Hypertension meeting

Relypsa, Inc. today announced the presentation of positive results from a Phase 2 clinical trial of the company's lead compound, RLY5016, a non-absorbed oral potassium binder being developed as a treatment for hyperkalemia (elevated serum potassium levels).

23 May 2011

Vertex receives FDA approval for INCIVEK to treat hepatitis C

Vertex Pharmaceuticals Incorporated announced that the U.S. Food and Drug Administration (FDA) has approved INCIVEK™ (telaprevir) tablets for a broad group of people with genotype 1 chronic hepatitis C with compensated liver disease (some level of damage to the liver but the liver still functions), including cirrhosis (scarring of the liver).

23 May 2011

Healthways, BCBSNC to offer SilverSneakers to Blue Medicare HMO and PPO members

In a continuing effort to promote well-being and prevention to its older-adult members, Blue Cross and Blue Shield of North Carolina (BCBSNC) and Healthways, the leading well-being improvement company, have agreed to offer the award-winning SilverSneakers Fitness Program to BCBSNC's eligible Blue Medicare Supplement members beginning June 1, 2011.

23 May 2011

Nano-complex pre-meal dietary supplement can reduce fat and sugar absorption in the body

A little bitter with a little sweet, in the form of a nano-complex dietary supplement taken before meals, can result in a substantial reduction of fat and sugar absorption in the body, Hebrew University of Jerusalem and Harvard University researchers have found.

23 May 2011

Millennium Laboratories founder to be honored as 2011 Ernst & Young Entrepreneur for pain care

Millennium Laboratories, a leading provider of medication monitoring services to physicians and staff treating chronic pain, announced today that James Slattery, CEO and founder, is a regional finalist for the Ernst & Young Entrepreneur of the Year 2011 San Diego region.

23 May 2011

Novel compound could become an effective alternative to common narcotic analgesics

Scientists from the Florida campus of The Scripps Research Institute have for the first time accomplished a laboratory synthesis of a rare natural product isolated from the bark of a plant widely employed in traditional medicine.

23 May 2011

Chronic News and Research

HDL to acquire Harris Scientific

New cancer study finds benefit in old therapy

Nerve stimulation device approved for pain

Disaster-response planning raises challenges for mental health services, bioethicists say

Galectin-3 research uncovers new use for Modified Citrus Pectin in cardiovascular, heart disease

Analysis of Nubian-era mummies finds schistosomiasis spread from altering environment

NIAID team completes analysis of most proteins produced by elephantiasis parasite worm

Ford engineers develop car seat that can monitor driver's heartbeat

RACGP urges government to engage with profession regarding GP mental health funding cuts

NIH awards $3.03 million grant to UTMB researcher to continue groundbreaking aging study

Vertex Incivek receives FDA approval for treatment of chronic hepatitis C

Terminally ill missing out on palliative care: Survey reports

Johns Hopkins bioethicists urge disaster preparedness for mentally impaired

HIV-infected donors present novel source of organs for HIV-infected transplant candidates

Positive results from Relypsa RLY5016 Phase 2 trial to be presented at American Society of Hypertension meeting

Vertex receives FDA approval for INCIVEK to treat hepatitis C

Healthways, BCBSNC to offer SilverSneakers to Blue Medicare HMO and PPO members

Nano-complex pre-meal dietary supplement can reduce fat and sugar absorption in the body

Millennium Laboratories founder to be honored as 2011 Ernst & Young Entrepreneur for pain care

Novel compound could become an effective alternative to common narcotic analgesics

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News